Skip to content

BillionToOne, Inc. BLLN Accrued Liabilities & Other

Accrued Liabilities & Other at other companies

Lantheus Holdings logo
Lantheus HoldingsLNTH
$286.49M+41.6%
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
$48.2M+72.8%

Other financials

Income statement

See full
Revenue$108.4M+83.8%
Gross profit$79.1M+108%
Operating income$17.8M+870%
Net income$18.0M+551%
EPS (diluted)$0.34+187%

Balance sheet

See full
Cash & equivalents$537.5M+181%
Total debt$144.2M
Total equity$505.6M+300%
Total assets$700.7M

Cash flow

See full
Operating cash flow$15.4M+488%
CapEx$4.5M+90.5%
Free cash flow$11.0M+3,842%

Valuation

See full
Market cap$4.84B

Profitability

See full
Gross margin70.4%
Operating margin-96.9%
Net margin8.4%
FCF margin-83.4%

Returns & leverage

See full
Debt / equity0.3×
Current ratio10.9×

Where this comes from

Reported directly by BillionToOne, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent.

The official record: BillionToOne, Inc. ’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about BillionToOne, Inc. 's accrued liabilities & other.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is BillionToOne, Inc. 's accrued liabilities & other?
BillionToOne, Inc. (BLLN) reported accrued liabilities & other of $8.63M in Q1 2026.
What does accrued liabilities & other mean?
Combined accrued expenses and miscellaneous current liabilities not classified in specific categories.